Skip to content

Effectiveness of Pulmonary rehabilitation program delivered remotely to patients with Interstitial Lung Disease

Effectiveness of Pulmonary Tele-rehabilitation program in patients with Interstitial Lung disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/01/049165
Enrollment
40
Registered
2023-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J841- Other interstitial pulmonary diseases with fibrosis

Interventions

Intervention1: supervised tele-rehabilitation sessions 3 day/week for 6 weeks: Supervised exercise training will include aerobic/endurance, strength training and breathing exercises. o Aerobic train

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)All patients 18-75 years of age of both sex. 2)Patients diagnosed as ILD on clinical, radiological, and pathological basis as per the American Thoracic Society (ATS)/ European Respiratory society (ERS) criteria due to any cause. 3)Clinically stable patients without exacerbations in the past 3 months.

Exclusion criteria

Exclusion criteria: 1)Patients with respiratory disorders other than ILD such as acute infections, COPD, bronchiectasis, lung carcinoma, pneumothorax, pulmonary tuberculosis. 2)Patients with comorbidities preventing them to perform exercise training such as disability due to cardiac disease, neurological or orthopedic cause. 3)Already participated or completed a PR program in the past 1 year.

Design outcomes

Primary

MeasureTime frame
1) Functional capacity measured using the 6-minute walk test. 2) Pulmonary function test to assess the lung function. Timepoint: Baseline assessment pre intervention and assessment post intervention after 6 weeks.

Secondary

MeasureTime frame
1) 30s chair sit to stand test for peripheral muscle performance of lower limb. 2) Kingâ??s Brief Interstitial Lung Disease is a disease specific measure to assess the effect of rehabilitation on health related quality of life. Timepoint: Baseline assessment pre intervention and assessment post intervention after 6 weeks.

Countries

India

Contacts

Public ContactDr Aditi Singh

Amity Institute of Physiotherapy

asingh29@amity.edu7737402909

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026